Novel controlled and targeted releasing hydrogen sulfide system exerts combinational cerebral and myocardial protection after cardiac arrest
نویسندگان
چکیده
Abstract Background Cardiac arrest (CA) is a leading cause of death worldwide. Even after successful cardiopulmonary resuscitation (CPR), the majorities survivals are companied with permanent myocardial and cerebral injury. Hydrogen sulfide (H 2 S) has been recognized as novel gasotransmitter exerting multiple organ protection; however, lacks ideal H S donors which can controlled release to targeted organs such heart brain limits its application. Results This work utilized mesoporous iron oxide nanoparticle (MION) carriers diallyl trisulfide (DATS), polyethylene glycol (PEG) lactoferrin (LF) modified MIONs acquire prolonged circulation time brain-targeting effects, releasing system was constructed (DATS@MION-PEG-LF), exhibited excellent biocompatibility, controlled-releasing pattern, targeting features, ability be non-invasive traced by magnetic resonance imaging. DATS@MION-PEG-LF presented potent protective effects against cardiac ischemic injury CA in both vitro hypoxia/reoxygenation models vivo CA/CPR models, mainly involves anti-apoptosis, anti-inflammatory anti-oxidant mechanisms. Accordingly, functions were obviously improved CA/CPR, potentially survival. Conclusions The present provides unique platform for based on MIONs, offers new method combinational protection from injury, bringing considerable benefits patients.
منابع مشابه
Hydrogen sulfide-releasing aspirin derivative ACS14 exerts strong antithrombotic effects in vitro and in vivo.
OBJECTIVE Hydrogen sulfide (H(2)S)-releasing NSAIDs exert potent anti-inflammatory effects beyond classical cyclooxygenase inhibition. Here, we compared the platelet inhibitory effects of the H(2)S-releasing aspirin derivative ACS14 with its mother compound aspirin to analyze additional effects on platelets. METHODS AND RESULTS In platelets of mice fed with ACS14 for 6 days (50 mg/kg per day)...
متن کاملMyocardial Dysfunction and Shock after Cardiac Arrest
Postarrest myocardial dysfunction includes the development of low cardiac output or ventricular systolic or diastolic dysfunction after cardiac arrest. Impaired left ventricular systolic function is reported in nearly two-thirds of patients resuscitated after cardiac arrest. Hypotension and shock requiring vasopressor support are similarly common after cardiac arrest. Whereas shock requiring va...
متن کاملMAVS Mediates Protection against Myocardial Ischemic Injury with Hydrogen Sulfide
Background: Hydrogen sulfide (H 2 S) has been shown to protect against myocardial ischemic and inflammatory injury in part by preserving mitochondrial integrity. Since mitochondrial antiviral signaling (MAVS) protein has been implicated in attenuating Bax-mediated cytochrome c release from mitochondria caused by oxidative stress or ischemia, we sought to determine whether MAVS mediates the card...
متن کاملHypothermic arrest and potassium arrest: metabolic and myocardial protection during elective cardiac arrest.
Hypothermic arrest, potassium arrest, and ischemic arrest, either singly or in combination, with or without coronary perfusion were studied in an isolated perfused rat heart preparation. Procedures that permitted the maintenance of high cellular levels of adenosine triphosphate (ATP) and creatine phosphate during arrest, e.g., coronary perfusion with hypothermic solutions or solutions containin...
متن کاملTargeted therapeutic mild hypercapnia after cardiac arrest
Cardiac arrest (CA) causes ischaemic brain injury and persistent cerebral hypoperfusion and cerebral hypoxia during the early post-resuscitation period. PaCO2 is the major physiological regulator of cerebral blood flow, is a modifiable component of care and mild hypercapnia may lead to improved neurological outcomes for resuscitated CA survivors. In order to evaluate the potential therapeutic r...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Nanobiotechnology
سال: 2021
ISSN: ['1477-3155']
DOI: https://doi.org/10.1186/s12951-021-00784-w